Every year, the American Society of Clinical Oncology Annual Meeting provides a platform for sharing exciting new cancer therapies. In 2025, MD Anderson clinicians and researchers will present more than 120 studies. Five stand out for their potential to change the way cancers are treated.

They include therapies for thyroid cancer, colorectal cancer and a rare type of leukemia. The studies represent a variety of first-in-class approaches for treating cancer, from a lipid nanoparticle-encapsulated mRNA to a new oral small molecule inhibitor.